Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

23
Number of overlapping holdings
82.1%
% of PBE's 28 holdings also in XBI
17.3%
% of XBI's 134 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in XBI |
Overlap | |
---|---|---|---|---|
NEUROCRINE BIOSCIENCES INC | 3.2% | 2.8% | 2.8% | |
NATERA INC | 5.3% | 2.5% | 2.5% | |
GILEAD SCIENCES INC | 5.3% | 2.5% | 2.5% | |
AMGEN INC | 4.8% | 2.4% | 2.4% | |
INCYTE CORP | 5.0% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to XBI
ILLUMINA INC | 4.6% | |
ROYALTY PHARMA PLC CLASS A | 3.2% | |
AXSOME THERAPEUTICS, INC. | 3.0% | |
GILEAD SCIENCES INC | 2.9% | |
NATERA INC | 2.9% | |
COLLEGIUM PHARMACEUTICAL, INC. | 2.8% | |
BIO-TECHNE CORPORATION | 2.7% | |
INCYTE CORP | 2.6% | |
BIOCRYST PHARMACEUTICALS INC | 2.6% | |
ACADIA PHARMACEUTICALS INC | 2.6% |
PBE Underweight Relative to XBI
ALNYLAM PHARMACEUTICALS INC | -2.5% | |
ABBVIE INC | -2.5% | |
INSMED INC | -2.4% | |
VERTEX PHARMACEUTICALS INC | -2.3% | |
VAXCYTE, INC. | -2.3% | |
MODERNA, INC. | -2.1% | |
MADRIGAL PHARMACEUTICALS, INC. | -1.9% | |
VIKING THERAPEUTICS, INC. | -1.5% | |
BRIDGEBIO PHARMA, INC. | -1.5% | |
ADMA BIOLOGICS, INC. | -1.4% |